Lv1
75 积分 2021-04-12 加入
Pharmacokinetics, mass balance, and metabolism of [14C]PLB1004, a selective and irreversible EGFR-TKI in humans
3个月前
已完结
Radiotherapy has a role to play in patients with EGFR-mutated non-small-cell lung cancer in first-line treatment
5个月前
已完结
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
5个月前
已完结
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
5个月前
已完结
Association Between Age and Survival Trends in Advanced Non–Small Cell Lung Cancer After Adoption of Immunotherapy
6个月前
已完结
Immune-Related Adverse Events in Patients with Lung Cancer
6个月前
已完结
老年人晚期非小细胞肺癌免疫治疗的研究进展
6个月前
已完结
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
6个月前
已完结
Pleural mesothelioma
6个月前
已完结
Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation
8个月前
已完结
皖公网安备34019202002308
